Evidence map›Paper›PMID 31466406›Full record

ArticlePolymers2019

Preparation of Modified Chitosan Microsphere-Supported Copper Catalysts for the Borylation of α,β-Unsaturated Compounds.

Wei Wang, Zufeng Xiao, Chaofan Huang, Kewang Zheng, Yin Luo, Yumin Dong, Zitong Shen, Wei Li, Caiqin Qin

Abstract read
In one paragraph

Article in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Copper Foam as Active Catalysts for the Borylation ofInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei WangSchool of Chemistry and Materials Science, Hubei Engineering University, Xiaogan 432000, China.
Zufeng XiaoSchool of Chemistry and Materials Science, Hubei Engineering University, Xiaogan 432000, China.
Chaofan HuangSchool of Chemistry and Materials Science, Hubei Engineering University, Xiaogan 432000, China.
Kewang ZhengSchool of Chemistry and Materials Science, Hubei Engineering University, Xiaogan 432000, China.
Yin LuoSchool of Chemistry and Materials Science, Hubei Engineering University, Xiaogan 432000, China.
Yumin DongSchool of Chemistry and Materials Science, Hubei Engineering University, Xiaogan 432000, China.
Zitong ShenSchool of Chemistry and Materials Science, Hubei Engineering University, Xiaogan 432000, China.
Wei LiSchool of Chemistry and Materials Science, Hubei Engineering University, Xiaogan 432000, China. weili@hbeu.edu.cn.
Caiqin QinSchool of Chemistry and Materials Science, Hubei Engineering University, Xiaogan 432000, China. qincq@hbeu.edu.cn.

Funding

the Science and Technology Department of Hubei Province of China 2018ACA152
6 · The paper itself

Abstract

Chitosan microspheres modified by 2-pyridinecarboxaldehyde were prepared and used in the construction of a heterogeneous catalyst loaded with nano-Cu prepared by a reduction reaction. The chemical structure of the catalyst was investigated by Fourier Transform Infrared Spectroscopy (FT-IR), Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), and X-ray Photoelectron Spectroscopy (XPS). Under mild conditions, such as no ligand at room temperature, the catalyst was successfully applied to catalyze the borylation of α,β-unsaturated receptors in a water-methanol medium, yielding 17%-100% of the corresponding -hydroxy product. Even after repeated use five times, the catalyst still exhibited excellent catalytic activity.

Indexed as

chitosan microspherescopperorganoboron compounds

Identifiers

PMID31466406
PMCPMC6788198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.